FDA designation may speed new treatment for Alzheimer’s psychosis
The U.S. Food and Drug Administration (FDA) has granted fast track designation to remlifanserin, an experimental treatment that Acadia Pharmaceuticals […]
The U.S. Food and Drug Administration (FDA) has granted fast track designation to remlifanserin, an experimental treatment that Acadia Pharmaceuticals […]
I have no words of wisdom to comfort those whose loved one has Alzheimer’s. Of all the diseases, there is
Long before lifestyle medicine went mainstream, ARPF was uncovering the science of brain health and longevity. Today, as prevention takes
Dear friends, Many leading scientists have recently said that there is up to a 30% chance that AI will take
When Malaika Albrecht, RYT200, BLS, first came across the Brain Longevity Therapy Training (BLTT) in a Yoga Alliance newsletter, she
By Kirti Khalsa, ARPF CEO On June 11–13, 2026, the global yoga therapy community gathered in Costa Mesa, California, for
Listen or Subscribe to Alzheimer’s Speaks Podcast on Apple #BoldCareLeader #4MindsetShifts #5BreakthroughCarePillars Lori La Bey talks with Mark Wilson, who
The Alzheimer’s Research and Prevention Foundation is a leading-edge non-profit organization that has been funding integrative medical research on the
A special commemoration for donations made in Memory and in Honor. Your ARPF is humbled to help remember your loved ones.
Listen or Subscribe to Alzheimer’s Speaks Podcast on Apple #BoldCareLeader #4MindsetShifts #5BreakthroughCarePillars Lori La Bey talks with Mark Wilson, who